Citation Impact
Citing Papers
Diabetes and Cardiovascular Disease
1999 Standout
Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBβ)
2001 StandoutScience
Podocin and MEC-2 bind cholesterol to regulate the activity of associated ion channels
2006 StandoutNobel
Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy.
1988
Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy.
1989
1998 clinical practice guidelines for the management of diabetes in Canada
1998
Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
2014 Standout
La carga de enfermedad, lesiones, factores de riesgo y desafíos para el sistema de salud en México
2013
The course of kidney function in Type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy
1993
Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European Type 2 (non-insulin-dependent) diabetic patients
1991
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance
2006
Progression of nephropathy in type 2 diabetic patients
2004
Pathophysiology of Progressive Nephropathies
1998 Standout
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
2018 Standout
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
2006 Standout
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
Diabetic renal disease: from recent studies to improved clinical practice
2004
An Overview of Renal Pathology in Insulin-Dependent Diabetes Mellitus in Relationship to Altered Glomerular Hemodynamics
1992
The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes
2001 Standout
Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
2001 Standout
The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-aged Men
2002 Standout
National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants
2011 Standout
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>
2003 Standout
The metabolic syndrome
2010 Standout
Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes
2001 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
2009 Standout
MICROALBUMINURIA AS PREDICTOR OF VASCULAR DISEASE IN NON-DIABETIC SUBJECTS
1988
Adipocytes as regulators of energy balance and glucose homeostasis
2006 StandoutNature
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus.
1992
Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X
2003
Glomerular size-selective dysfunction in NIDDM is not ameliorated by ACE inhibition or by calcium channel blockade
1999
Renal Insufficiency in the Absence of Albuminuria and Retinopathy Among Adults With Type 2 Diabetes Mellitus
2003
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study
1997
Diabetic Retinopathy
2012 Standout
Chronic proteinuric nephropathies: Outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury
2000
Pathologic Classification of Diabetic Nephropathy
2010 Standout
The metabolic syndrome
2005 Standout
Magnesium reduces insulin-stimulated glucose uptake and serum lipid concentrations in type 1 diabetes
2001
NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome
2000
Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
2002 Standout
Angiotensin-Converting Enzyme Inhibitor–Associated Elevations in Serum Creatinine
2000
The Paradox of the Low-Renin State in Diabetic Nephropathy
1999
Global and societal implications of the diabetes epidemic
2001 StandoutNature
Development and Progression of Renal Disease in Pima Indians with Non-Insulin-Dependent Diabetes Mellitus
1996
Insulin signalling and the regulation of glucose and lipid metabolism
2001 StandoutNature
Long-Term Complications of Diabetes Mellitus
1993 Standout
Patterns of renal injury in NIDDM patients with microalbuminuria
1996
Estrogen plus Progestin and the Risk of Coronary Heart Disease
2003 Standout
Albuminuria and Risk of Cardiovascular Events, Death, and Heart Failure in Diabetic and Nondiabetic Individuals
2001 Standout
Mechanisms for Insulin Resistance: Common Threads and Missing Links
2012 Standout
Serum and Dietary Magnesium and the Risk for Type 2 Diabetes Mellitus
1999
Risk factors for renal replacement therapy in the Early Treatment Diabetic Retinopathy Study (ETDRS), Early Treatment Diabetic Retinopathy Study Report No. 26
2004
Different patterns of renal damage in type 2 diabetes mellitus: A multicentric study on 393 biopsies
2002
The effect of RAAS blockade on the progression of diabetic nephropathy
2013
The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy
1993 Standout
Microalbuminuria is not rare before 5 years of IDDM
1994
Reversal of Lesions of Diabetic Nephropathy after Pancreas Transplantation
1998 Standout
Renal function and structure in albuminuric type 2 diabetic patients without retinopathy
2001
Prevention of fat-induced insulin resistance by salicylate
2001
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
2015 Standout
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
The possible role of postprandial hyperglycaemia in the pathogenesis of diabetic complications
2003
Evolution, consequences and future of plant and animal domestication
2002 StandoutNature
Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview
2000 Standout
Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with Type II diabetes
2001
Activation of Oxidative Stress by Acute Glucose Fluctuations Compared With Sustained Chronic Hyperglycemia in Patients With Type 2 Diabetes
2006 Standout
Causes of albuminuria in patients with type 2 diabetes without diabetic retinopathy
2000
Treatment of Hypertension in Type 2 Diabetes Mellitus: Blood Pressure Goals, Choice of Agents, and Setting Priorities in Diabetes Care
2003
The Rising Global Burden of Diabetes and its Complications: Estimates and Projections to the Year 2010
1997
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials
2003 Standout
Diabetes mellitus and hypertension.
1992
Diabetic Nephropathy: Diagnosis, Prevention, and Treatment
2005 Standout
Effects of Calcium Antagonists on Renal Hemodynamics and Progression of Nondiabetic Chronic Renal Disease
1994
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
Utility of Untimed Urinary Albumin Measurements in Assessing Albuminuria in Black NIDDM Subjects
1997
Safety and Efficacy of Repaglinide in Type 2 Diabetic Patients With and Without Impaired Renal Function
2003
Decreasing Incidence of Severe Diabetic Microangiopathy in Type 1 Diabetes
2003
Magnesium in Prevention and Therapy
2015 Standout
Captopril or conventional therapy in hypertensive type II diabetics. Three-year analysis.
1993
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
2002
Comparative Study of the Effect of ACE-Inhibitors and Other Antihypertensive Agents on Proteinuria in Diabetic Patients
1994
The Early Natural History of Nephropathy in Type 1 Diabetes
2002
Nephropathy of type-2 diabetes mellitus.
1998
Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ
2001 StandoutScience
Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.
1991
Nonalbuminuric Renal Insufficiency in Type 2 Diabetes
2004
Mechanism of Insulin Resistance in A-ZIP/F-1 Fatless Mice
2000
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
2020 Standout
Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus
2016
Pharmacologic Therapy for Type 2 Diabetes Mellitus
1999
Renal Outcome in Type 2 Diabetic Patients With or Without Coexisting Nondiabetic Nephropathies
2002
Global Prevalence of Diabetes
2004 Standout
Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role ofPGC1andNRF1
2003 Standout
Prevalence of Arterial Hypertension in Diabetic Patients Before and After the JNC-V
1994
The nephropathy of non-insulin-dependent diabetes
1998
Glomerular structure and function in proteinuric Type 2 (non-insulin-dependent) diabetic patients
1993
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults
2013 Standout
Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes
2003 Standout
The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient?
2000
Microalbuminuria as a Risk Predictor in Diabetes: The Continuing Saga
2014
Dapagliflozin in Patients with Chronic Kidney Disease
2020 Standout
Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans.
2000
Predictors of the development of microalbuminuria in patients with Type 1 diabetes mellitus: a seven‐year prospective study
1999
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin
2002 Standout
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
2002 Standout
Works of P. Skøtt being referenced
Prevalence of microalbuminuria, arterial hypertension, retinopathy, and neuropathy in patients with insulin dependent diabetes
1988
Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients
1992
Insulin Increases Renal Magnesium Excretion: A Possible Cause of Magnesium Depletion in Hyperinsulinaemic States
1995
Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus.
1991
Placebo-Controlled Comparison of Captopril, Metoprolol, and Hydrochlorothiazide Therapy in Non - Insulin-Dependent Diabetic Patients With Primary Hypertension
1992
Effects of hyperglycaemia on kidney function, atrial natriuretic factor and plasma renin in patients with insulin-dependent diabetes mellitus
1991
Hyperglycaemia enhances renal magnesium excretion in Type 1 diabetic patients
2000
Glucose–fatty acid cycle operates in humans at the levels of both whole body and skeletal muscle during low and high physiological plasma insulin concentrations
1994
Impact of Lisinopril and Atenolol on Kidney Function in Hypertensive NIDDM Subjects With Diabetic Nephropathy
1994
Long-Term Effect of Lisinopril and Atenolol on Kidney Function in Hypertensive NIDDM Subjects With Diabetic Nephropathy
1997
Lithium clearance in the evaluation of segmental renal tubular reabsorption of sodium and water in diabetes mellitus.
1994
Lithium clearance and renal tubular sodium handling during acute and long-term nifedipine treatment in essential hypertension
1988